WELL Health Technologies (TSE:WELL) Reaches New 52-Week High on Analyst Upgrade

WELL Health Technologies Corp. (TSE:WELL)’s share price hit a new 52-week high during trading on Monday after Raymond James raised their price target on the stock from C$10.00 to C$11.00. The stock traded as high as C$7.05 and last traded at C$7.02, with a volume of 967704 shares changing hands. The stock had previously closed at C$6.79.

Other analysts have also issued reports about the stock. TD Securities lifted their price target on shares of WELL Health Technologies from C$8.00 to C$8.50 in a research note on Tuesday. Ventum Financial cut their target price on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating for the company in a research report on Tuesday, October 29th. Haywood Securities raised their target price on WELL Health Technologies from C$8.00 to C$10.00 in a report on Friday, December 13th. CIBC lifted their target price on WELL Health Technologies from C$5.25 to C$7.00 in a research report on Friday, December 13th. Finally, Scotiabank upped their price target on WELL Health Technologies from C$6.00 to C$7.00 in a research report on Monday.

WELL Health Technologies Stock Performance

The firm has a 50-day moving average price of C$5.24 and a two-hundred day moving average price of C$4.73. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02. The firm has a market capitalization of C$1.77 billion, a P/E ratio of 12.44, a P/E/G ratio of -1.93 and a beta of 1.20.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.